Nanocarriers in Tuberculosis Treatment: Challenges and Delivery Strategies

The World Health Organization identifies tuberculosis (TB), caused by <i>Mycobacterium tuberculosis</i>, as a leading infectious killer. Although conventional treatments for TB exist, they come with challenges such as a heavy pill regimen, prolonged treatment duration, and a strict schedule, leading...

Descripción completa

Detalles Bibliográficos

Autores principales:	Mahesh Kumar, Tarun Virmani, Girish Kumar, Rohitas Deshmukh, Ashwani Sharma, Sofia Duarte, Pedro Brandão, Pedro Fonte
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	MDPI AG 2023-09-01
Colección:	Pharmaceuticals
Materias:	tuberculosis ligand nanoformulation nanoparticle patent mannose
Acceso en línea:	https://www.mdpi.com/1424-8247/16/10/1360
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!